ARTICLE | Clinical News
Pfizer preclinical data
November 11, 2002 8:00 AM UTC
Researchers published in Nature that in a mouse model of MS, atorvastatin treatment significantly ameliorated symptoms when given either before or after disease onset (p<0.001). The researchers sugges...